Cargando…
The trace aminergic system: a gender-sensitive therapeutic target for IBS?
Due to a lack of specific or sensitive biomarkers, drug discovery advances have been limited for individuals suffering from irritable bowel syndrome (IBS). While current therapies provide symptomatic relief, inflammation itself is relatively neglected, despite the presence of chronic immune activati...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520957/ https://www.ncbi.nlm.nih.gov/pubmed/32981524 http://dx.doi.org/10.1186/s12929-020-00688-1 |